US regulators approve 2nd gene therapy for blood cancer
U.S. regulators have approved a second gene therapy for blood cancer.
Highmark's Allegheny Health Network announces $1B expansion
Highmark Health will spend $1 billion to expand its Allegheny Health Network hospital chain, including a new 160-bed hospital in Pittsburgh's North Hills suburbs, four smaller neighborhood hospitals, and renovations to existing hospitals, the Pittsburgh-based company announced Wednesday.
Ohio launches $8M search for tech-based opioid crisis solution
The state of Ohio launched an $8 million initiative on Wednesday, asking experts for technology-based proposed solutions to the national opioid crisis that has touched scores of families, including that of Columbus mother Jacqueline Lewis, who said solutions can't come too soon.
Toyota recalls some Sienna minivans for shifter defect
Toyota Motor Co. is recalling 347,120 Sienna minivans worldwide because they can shift out of the "park" position and roll away.
Trump slams new bipartisan health care deal: What's in it?
Following negotiations that lasted for more than a month, Sen. Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.) have reached a deal to stabilize the insurance markets, just two weeks before the ObamaCare open enrollment period is set to begin.
Anthem will turn to CVS after troubled Express Scripts deal
Anthem has found a new partner to help run prescription drug coverage after the Blue Cross-Blue Shield insurer's rocky relationship with Express Scripts ends.
Ford recalling about 1.3M vehicles for possible door issue
Ford is recalling about 1.3 million 2015-17 F-150 and 2017 Super Duty vehicles in North America because of potential door problems.
U.S. senators reach bipartisan deal on Obamacare, Trump indicates support
Two U.S. senators on Tuesday reached a bipartisan agreement to shore up Obamacare for two years by reviving federal subsidies for health insurers that President Donald Trump planned to scrap, and the president indicated his support for the plan.
Trump signals support for bipartisan deal to fund health care subsidies
Health care subsidies deal
Rand Paul threatens to vote down GOP budget, potentially jeopardizing tax cuts
Sen. Rand Paul (R-Ky.) is on the fence about the costs of the budget proposal and, where it stands now, he may not be able to support the measure, a source familiar with the matter told FOX Business on Tuesday.
Johnson & Johnson tops Street 3Q forecasts, hikes forecast
Johnson & Johnson is reporting third-quarter earnings of $3.76 billion.
UnitedHealth beats 3Q forecasts, helped by Optum growth
UnitedHealth Groups' third-quarter earnings soared 26 percent to beat Wall Street expectations as its growing Optum business segment once again helped the nation's largest health insurer.
Trump declaring state of emergency on opioids an 'excellent thing,' Ron Ferguson says
GoGoMeds.com CEO Ron Ferguson on the fight against America’s opioid crisis.
UnitedHealth's profit rises 26.3%
UnitedHealth Group, the largest U.S. health insurer, reported a stronger-than-expected quarterly profit and raised its full-year adjusted earnings forecast, helped by growth across all its businesses.
Wolf blames Trump, Congress for spiking health coverage cost
Democratic Gov. Tom Wolf's administration on Monday blamed President Donald Trump and the Republican-led Congress for a sharp increase in the cost of health insurance that will take effect next year for some of the 500,000-plus people who buy individual plans in Pennsylvania.
Business owner faces backlash for attending Trump signing
A Massachusetts business owner photographed last week with President Donald Trump is facing heavy criticism.
Investors should expect 'years' of health care reform related uncertainty
Most major health care stocks were lower on Monday, continuing their descent since the White House confirmed last week that it would halt federal payments for cost-sharing reduction (CSR) payments to health insurers.
Business owner on how ObamaCare impacted his company
ObamaCare subsidies
Exelixis liver cancer drug meets late-stage goal, shares jump
Oct 16 (Reuters) - Exelixis Inc. (NASDAQ:EXEL) said on Monday its drug to treat patients with a type of liver cancer met the main goal in a late stage study, sending its shares up 19 percent in premarket trading.
Trump Obamacare move seen harming Americans, bipartisan prospects
U.S. President Donald Trump will hurt low-income Americans by doing away with Obamacare subsidies and make it harder for him to engage in bipartisan talks with Democrats as Congress edges toward a possible government shutdown, lawmakers said on Sunday.
















